A double blind, placebo controlled, parallel group, multicenter study to assess the duration of action, safety and toleration of differing doses and combinations of immediate and modified release formulations of UK-369,003 and cialis [tadalafil] compared to placebo in adult male subjects with erectile dysfunction

Trial Profile

A double blind, placebo controlled, parallel group, multicenter study to assess the duration of action, safety and toleration of differing doses and combinations of immediate and modified release formulations of UK-369,003 and cialis [tadalafil] compared to placebo in adult male subjects with erectile dysfunction

Completed
Phase of Trial: Phase II

Latest Information Update: 02 Jun 2011

At a glance

  • Drugs Gisadenafil; Tadalafil
  • Indications Erectile dysfunction
  • Focus Therapeutic Use
  • Most Recent Events

    • 29 Aug 2006 Status change
    • 29 Oct 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top